US Patent Issued to JUNTENDO EDUCATIONAL FOUNDATION on Feb. 3 for "Therapeutic agent for hypertrophic cardiomyopathy" (Japanese Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,539,285, issued on Feb. 3, was assigned to JUNTENDO EDUCATIONAL FOUNDATION (Bunkyo-ku, Japan).

"Therapeutic agent for hypertrophic cardiomyopathy" was invented by Yasushi Okazaki (Bunkyo-ku, Japan), Atsuko Okazaki (Bunkyo-ku, Japan), Osamu Minowa (Bunkyo-ku, Japan), Hideo Saotome (Bunkyo-ku, Japan), Yukiko Yatsuka (Bunkyo-ku, Japan), Katsuharu Tsuchida (Bunkyo-ku, Japan) and Noriko Ichino (Bunkyo-ku, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A therapeutic agent may be effective for hypertrophic cardiomyopathy. The therapeutic agent may include 5-aminolevulinic acid, an ester thereof, or a salt thereof, as an active ingredient. A method for tre...